Image
ST. PAUL, MN
The Minnesota Department of Health has released the state’s first comprehensive Viral Hepatitis Elimination Plan, establishing a coordinated, multi-year strategy aimed at sharply reducing infections and deaths tied to hepatitis A, B, and C.
The plan, officially published April 9, 2026, marks the first time Minnesota has adopted a unified, statewide framework to address viral hepatitis across prevention, diagnosis, treatment, and public health response. Health officials say the effort is designed to align Minnesota with national and global targets to reduce the disease as a major public health threat by 2030.
At the center of the strategy is a definition of “elimination” grounded in benchmarks set by the World Health Organization and the Centers for Disease Control and Prevention. Under those standards, elimination does not mean zero cases. Instead, it is defined as a 90 percent reduction in new infections and a 65 percent reduction in hepatitis-related deaths.
State health officials organized the plan around four primary pillars, each tied to specific, measurable actions. In total, the document outlines more than 100 steps intended to guide implementation over the next several years.
The first pillar, diagnosis, focuses on increasing the number of Minnesotans who know their hepatitis status. This includes expanding routine “opt-out” testing in correctional facilities and increasing rapid screening in community-based settings, where individuals at higher risk are more likely to be reached.
Prevention forms the second pillar, with an emphasis on increasing vaccination rates for hepatitis A and B while supporting harm reduction strategies that limit transmission. Health officials point to syringe service programs, education campaigns, and targeted outreach as key tools in preventing new infections.
The third pillar, treatment, centers on expanding access to care, particularly for hepatitis C, which is now curable through direct-acting antiviral medications. The plan calls for integrating hepatitis care into primary care settings, allowing more providers across the state to diagnose and treat patients without requiring specialist referral.
The fourth pillar, response, focuses on strengthening Minnesota’s disease surveillance systems. Officials say improved data tracking will allow for faster detection of outbreaks, more targeted interventions, and better long-term monitoring of health outcomes.
The elimination strategy was developed over the course of a year through monthly coordination among a coalition of 21 partner organizations. The group includes hospital systems, community-based organizations, harm reduction providers, and government agencies, including the Minnesota Department of Corrections.
Health officials say that collaboration was essential to ensuring the plan reflects both clinical realities and on-the-ground community needs. The approach is intended to bridge gaps between public health systems and populations that have historically faced barriers to care.

Despite existing strengths in Minnesota’s public health infrastructure, the plan identifies several ongoing challenges that could limit progress if not addressed.
One of the most significant is the gap between diagnosis and treatment. While testing capacity has expanded in recent years, not all individuals who receive a positive diagnosis are successfully connected to care. Health officials describe this “linkage to care” gap as a critical barrier to reducing long-term disease burden.
Affordability also remains a concern, particularly for hepatitis C medications. While highly effective, these treatments can be expensive, creating access challenges for uninsured or underinsured residents.
The report further highlights the need to expand hepatitis care within primary care settings. Currently, treatment is often concentrated among specialists, limiting statewide capacity and making it more difficult for patients in rural or underserved areas to receive timely care.
Public awareness is another factor. Health officials note that many individuals living with chronic hepatitis B or C may not be aware of their status, increasing the risk of untreated disease progression, including liver failure and liver cancer.
Viral hepatitis continues to pose a measurable health burden in Minnesota. Hepatitis A typically presents as an acute illness, sometimes leading to hospitalization during outbreaks. In contrast, hepatitis B and C often develop into chronic conditions, which can remain undetected for years while causing progressive liver damage.
According to the Minnesota Department of Health, these chronic infections are among the leading causes of liver cancer and liver-related deaths, underscoring the urgency behind the state’s elimination effort.
Minnesota enters this initiative with several established strengths, including a robust disease reporting system, expanded screening efforts in correctional facilities, and ongoing community-based testing programs. Officials say those systems will play a central role in tracking progress and refining the state’s approach over time.
Health officials confirmed that implementation of the plan is already underway, with agencies beginning to coordinate on priority actions outlined in the document. The Minnesota Department of Health will issue annual updates to measure progress, using data from its surveillance systems to assess whether the state is moving toward its 2030 targets.
The plan positions Minnesota within a broader national and international push to reduce viral hepatitis as a public health threat. By formalizing its strategy, state officials say Minnesota is shifting from fragmented efforts to a more coordinated, data-driven approach.
As implementation begins, the success of the plan will depend on sustained collaboration across healthcare systems, community organizations, and public agencies, as well as the state’s ability to close persistent gaps in access, affordability, and awareness.
MinneapoliMedia | Community. Culture. Civic Life.